Skip to main content
Log in

Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinoginic drugs

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Behavioral, electrophysiological and biochemical evidence suggest that the 5HT2 receptor plays a role in the action of hallucinogenic agents. Considering the structural and functional similarities between the 5HT2 and 5HT1C receptors, we hypothesized that the 5HT1C receptor may also be an important site of action of hallucinogens. The present manuscript evaluates this hypothesis by examining the properties of hallucinogens in the phenalkylamine and indolealkylamine classes at 5HT1C receptors. Epithelial cells isolated from the rat choroid plexus have a high density of 5HT1C receptors linked to phosphoinositide hydrolysis. Comparison of the actions of drugs in cultured cells and whole choroid plexus confirmed that the cell culture system can serve as an in vitro model of 5HT1C receptor activation. 2,5-Dimethoxy-4-bromoamphetamine (DOB), 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-iodoamphetamine (DOI) and 3,4-methylenedioxyamphetamine (MDA) were evaluated. The rank order of potency to activate 5HT1C receptors [(−)DOB>(±) DOI>(+)DOB>(−)DOM≫(−)MDA>(+) MDA] was consistent with the rank order of effective behavioral doses in rats and humans. The indolealkylamine hallucinogen, 5-methoxy-N,N-dimethyltryptamine was also a 5HT1C receptor agonist, as is the primary amine, 5-methoxytryptamine. These data, combined with previous studies showing that (+)LSD potently activates 5HT1C receptors, suggest that future investigations of the mechanism of action of hallucinogens should consider the role of 5HT1C receptors in addition to the more commonly investigated 5HT2 receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Berridge MJ, Downes CP, Hanley MR (1982) Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands Biochem J 206:587–595

    Google Scholar 

  • Bradford M (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–252

    Google Scholar 

  • Burris KD, Breeding MR, Sanders-Bush E (1991)(+)Lysergic acid diethylamide (LSD), but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist. J Pharmacol Exp Ther (in press)

  • Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant and the concentration of inhibitor that causes 50 percent inhibition of an enzymatic reaction. Biochem Pharmacol 22:3099–3108

    Google Scholar 

  • Conn PJ, Sanders-Bush E (1986) Agonist-induced phosphoinositide hydrolysis in choroid plexus. J Neurochem 47:1754–1760

    Google Scholar 

  • Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked 5HT-2 and 5HT-1C receptors

  • Conn PJ, Sanders-Bush E, Hoffman BJ, Hartig PR (1986) A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc Natl Acad Sci USA 83:4086–4088

    Google Scholar 

  • Crook RB, Kasagami H, Prusiner SB (1981) Culture and characterization of epithelial cells from bovine choroid plexus. J Neurochem 37:845–854

    Google Scholar 

  • Furchgott RF, Bursztyn P (1967) Comparison of dissociation constants and of relative efficacies of selected agonists acting on parasympathetic receptors. Ann NY Acad Sci 144:882–893

    Google Scholar 

  • Glennon RA (1987) Psychoactive phenylisopropylamines In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1627–1634

    Google Scholar 

  • Glennon RA (1990) Do classical hallucinogens act as 5HT2 agonists or antagonists? Neurophysychopharmacology 3:509–517

    Google Scholar 

  • Glennon RA, Titeler M, McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505–2511

    Google Scholar 

  • Hartig PR (1989) Molecular biology of 5-HT receptors. TIPS 10:64–69

    Google Scholar 

  • Hoffman BJ, Mezey E (1989) Distribution of serotonin 5HT1C receptor mRNA in adult rat brain. FEBS Lett 247:453–462

    Google Scholar 

  • Hoyer D, Pazos A, Probst A, Palacios JM (1986) Serotonin receptors in the human brain II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res 376:97–107

    Google Scholar 

  • Johanson CE (1988) The choroid plexus-arachnoid membrane-cerebrospinal fluid system. In: Boulton AA, Baker GB, Wolfgang W (eds) Neuromethods: the neuronal microenvironment. Humana Press, Clifton NJ, pp 33–104

    Google Scholar 

  • Kenakin TP (1987) Pharmacologic analysis of drug-receptor interaction. Raven Press, New York, pp 163–182

    Google Scholar 

  • Lyon RA, Glennon RA, Titeler M (1986) MDMA: stereospecific interactions at brain 5HT2 receptors. Psychopharmacology 88:525–526

    Google Scholar 

  • Molineaux SM, Jessell TM, Axel R, Julius D (1989) 5-HT1C receptor is a prominent serotonin receptor subtype in the central nervous system. Proc Natl Acad Sci USA 86:6793–6797

    Google Scholar 

  • Nichols DE, Oberlender R, Burris K, Hoffman AJ, Johnson MP (1989) Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA) analogues. Pharmacol Biochem Behav 34:571–576

    Google Scholar 

  • Pazos A, Hoyer D, Palacios JM (1984) The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur J Pharmacol 106:539–546

    Google Scholar 

  • Sanders-Bush E, Breeding M (1988) Putative selective 5HT-2 antagonists block serotonin 5HT-1C receptors in choroid plexus. J Pharmacol Exp Ther 247:169–173

    Google Scholar 

  • Sanders-Bush E, Breeding M (1990) Serotonin1C receptor reserve in choroid plexus masks receptor subsensitivity. J Pharmacol Exp Ther 252:984–988

    Google Scholar 

  • Sanders-Bush E, Burris KD, Knoth K (1988) Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. J Pharmacol Exp Ther 246:924–928

    Google Scholar 

  • Titeler M, Lyon RA, Glennon RA (1988) Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of actin for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94:213–216

    Google Scholar 

  • Tsutsumi M, Skinner MK, Sanders-Bush E (1989) Transferrin gene expression and synthesis by cultured choroid plexus epithelial cells: regulation by serotonin and cyclic 3'5'-adenosine monophosphate. J Biol Chem 264:9626–9631

    Google Scholar 

  • Yagaloff KA, Hartig PR (1985) 125I-Lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells. J Neurosci 5:3178–3183

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by ADAMHA research grant, DA 05181

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sanders-Bush, E., Breeding, M. Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinoginic drugs. Psychopharmacology 105, 340–346 (1991). https://doi.org/10.1007/BF02244428

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02244428

Key words

Navigation